TP53 and head and neck squamous cell carcinoma: If dependence on bcl-2 protein is associated with greater chimiosensitivity, even in tumours with p53 mutations, the molecular alterations related to bcl-2 positivity may have important implications on the rational approach to treatment of SCCHN.